Cytek Biosciences, Inc. (CTKB) NASDAQ
4.19
-0.05(-1.18%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.19
-0.05(-1.18%)
Currency In USD
| Market Cap | 645.12M |
| Enterprise Value | 578.01M |
| P/E Ratio | -7.29 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 2.65 |
| Price/Book Ratio | 1.65 |
| Enterprise/Revenue | 2.51 |
| Enterprise/EBITDA | -21.78 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.36 |
| Operating Margin | -0.21 |
| Return On Assets | -0.16 |
| Return On Equity | -0.21 |
| Revenue | 201.49M |
| Revenue/Share | 1.59 |
| Gross Profit | 104.46M |
| EBITDA | -17.39M |
| Net Income | -66.54M |
| Diluted EPS | -0.52 |
| Total Cash | 262.23M |
| Total Cash/Share | 2.04 |
| Total Debt | 36.33M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 4.69 |
| Book Value Per Share | 2.55 |
| 52-Week Change | 48.06 |
| 52-Week High | 6.18 |
| 52-Week Low | 2.76 |
| Moving Average 50 Days | 4.36 |
| Moving Average 200 Days | 4.48 |
| Average Volume | 801,349 |
| Shares Outstanding | 129.14M |
| % Held by Institutions | 66.59 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |